Indacaterol + Glycopyrrolate

Category: Lungs (Pulmonary)

Indacaterol + Glycopyrrolate Overview

Indacaterol (INN) is an ultra-long-acting beta-adrenoceptor agonist[1] developed by Novartis. It was approved by the European Medicines Agency (EMA) under the trade name Onbrez Breezhaler on November 30, 2009,[2] and by the United States Food and Drug Administration (FDA), under the trade name Arcapta Neohaler, on July 1, 2011.[3] It needs to be taken only once a day,[4] unlike the related drugs formoterol and salmeterol. It is l...

Read more Indacaterol + Glycopyrrolate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Indacaterol

Recent Indacaterol + Glycopyrrolate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Drugs with one or more similar ingredients: (12 results)

• UTIBRON NEOHALER Indacaterol + Glycopyrrolate
• ARCAPTA Indacaterol Maleate
• BEVESPI AEROSPHERE Glycopyrrolate + Formoterol Fumarate1 discussion
• CUVPOSA Glycopyrrolate
• GLYCOPYRROLATE 12 discussions
• GLYCOPYRROLATE + FORMOTEROL FUMARATE
• GLYRX-PF Glycopyrrolate
• INDACATEROL MALEATE 1 discussion
• LONHALA MAGNAIR KIT Glycopyrrolate
• ROBINUL Glycopyrrolate1 discussion
• ROBINUL INJECTABLE Glycopyrrolate
• SEEBRI NEOHALER Glycopyrrolate

Related Indacaterol + Glycopyrrolate Topics: